Fig. 5From: An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorderGraph showing quality-of-life scores over the course of the study, an increasing trend in the QOL score was observed upon completion of the study (p < 0.1 but > 0.05, p = 0.061)Back to article page